Strategies to decrease inequalities in cancer therapeutics, care and prevention - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Molecular Oncology Année : 2024

Strategies to decrease inequalities in cancer therapeutics, care and prevention

Ulrik Ringborg
  • Fonction : Auteur
Joachim von Braun
  • Fonction : Auteur
Julio Celis
  • Fonction : Auteur
Michael Baumann
Anton Berns
  • Fonction : Auteur
Alexander Eggermont
  • Fonction : Auteur
Edith Heard
  • Fonction : Auteur
Manuel Heitor
  • Fonction : Auteur
Mammen Chandy
  • Fonction : Auteur
Chien‐jen Chen
  • Fonction : Auteur
Alberto Costa
  • Fonction : Auteur
Francesco de Lorenzo
  • Fonction : Auteur
Edward de Robertis
  • Fonction : Auteur
Frederick Charles Dubee
  • Fonction : Auteur
Ingemar Ernberg
Mariya Gabriel
  • Fonction : Auteur
Åslaug Helland
  • Fonction : Auteur
Rui Henrique
Bengt Jönsson
  • Fonction : Auteur
Olli Kallioniemi
  • Fonction : Auteur
Jan Korbel
  • Fonction : Auteur
Mechthild Krause
Douglas Lowy
  • Fonction : Auteur
Olivier Michielin
  • Fonction : Auteur
Peter Nagy
  • Fonction : Auteur
Simon Oberst
Vincenzo Paglia
  • Fonction : Auteur
M. Iqbal Parker
Kevin Ryan
  • Fonction : Auteur
Charles Sawyers
  • Fonction : Auteur
Joachim Schüz
Katherine Silkaitis
  • Fonction : Auteur
David Thomas
  • Fonction : Auteur
Peter Turkson
  • Fonction : Auteur
Elisabete Weiderpass
  • Fonction : Auteur
Huanming Yang
  • Fonction : Auteur

Résumé

Analyses of inequalities related to prevention and cancer therapeutics/care show disparities between countries with different economic standing, and within countries with high Gross Domestic Product. The development of basic technological and biological research provides clinical and prevention opportunities that make their implementation into healthcare systems more complex, mainly due to the growth of Personalized/Precision Cancer Medicine (PCM). Initiatives like the USA‐Cancer Moonshot and the EU‐Mission on Cancer and Europe's Beating Cancer Plan are initiated to boost cancer prevention and therapeutics/care innovation and to mitigate present inequalities. The conference organized by the Pontifical Academy of Sciences in collaboration with the European Academy of Cancer Sciences discussed the inequality problem, dependent on the economic status of a country, the increasing demands for infrastructure supportive of innovative research and its implementation in healthcare and prevention programs. Establishing translational research defined as a coherent cancer research continuum is still a challenge. Research has to cover the entire continuum from basic to outcomes research for clinical and prevention modalities. Comprehensive Cancer Centres (CCCs) are of critical importance for integrating research innovations to preclinical and clinical research, as for ensuring state‐of‐the‐art patient care within healthcare systems. International collaborative networks between CCCs are necessary to reach the critical mass of infrastructures and patients for PCM research, and for introducing prevention modalities and new treatments effectively. Outcomes and health economics research are required to assess the cost‐effectiveness of new interventions, currently a missing element in the research portfolio. Data sharing and critical mass are essential for innovative research to develop PCM. Despite advances in cancer research, cancer incidence and prevalence is growing. Making cancer research infrastructures accessible for all patients, considering the increasing inequalities, requires science policy actions incentivizing research aimed at prevention and cancer therapeutics/care with an increased focus on patients' needs and cost‐effective healthcare.

Dates et versions

hal-04438452 , version 1 (05-02-2024)

Identifiants

Citer

Ulrik Ringborg, Joachim von Braun, Julio Celis, Michael Baumann, Anton Berns, et al.. Strategies to decrease inequalities in cancer therapeutics, care and prevention. Molecular Oncology, 2024, ⟨10.1002/1878-0261.13575⟩. ⟨hal-04438452⟩
10 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More